Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D0NG
|
||||
| Former ID |
DNC009012
|
||||
| Drug Name |
4-(cyclohexylmethylcarbamoyloxy)benzoic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529791] | ||
| Formula |
C15H19NO4
|
||||
| Canonical SMILES |
C1CCC(CC1)CNC(=O)OC2=CC=C(C=C2)C(=O)O
|
||||
| InChI |
1S/C15H19NO4/c17-14(18)12-6-8-13(9-7-12)20-15(19)16-10-11-4-2-1-3-5-11/h6-9,11H,1-5,10H2,(H,16,19)(H,17,18)
|
||||
| InChIKey |
UTXJJIRQAYXELZ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529791] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||